| Literature DB >> 22114824 |
Carrie A Thompson1, Karen Mauck, Rachel Havyer, Anjali Bhagra, Henna Kalsi, Sharonne N Hayes.
Abstract
Of those individuals diagnosed with Hodgkin lymphoma, 85% will survive and may be affected by residual effects of their cancer and its therapy (chemotherapy, radiation therapy, stem cell transplantation). Hodgkin lymphoma survivors are at risk of developing secondary malignancies, cardiovascular disease, pulmonary disease, thyroid disease, infertility, premature menopause, chronic fatigue, and psychosocial issues. These conditions usually have a long latency and therefore present years or decades after Hodgkin lymphoma treatment, when the patient's care is being managed by a primary care provider. This review summarizes these unique potential medical and psychologic sequelae of Hodgkin lymphoma, and provides screening and management recommendations.Entities:
Mesh:
Year: 2011 PMID: 22114824 PMCID: PMC3224339 DOI: 10.1016/j.amjmed.2011.05.020
Source DB: PubMed Journal: Am J Med ISSN: 0002-9343 Impact factor: 4.965